Navigation Links
Vaccine Stops Tumor Spread in Mice
Date:4/18/2010

Treatment may be used one day as part of cancer-fighting arsenal, but more study is needed

SUNDAY, April 18 (HealthDay News) -- A new study in mice suggests that a transcription factor normally found in male germ cells could become a target for cancer vaccines.

A transcription factor is a protein that controls the transfer (or transcription) of genetic material from the DNA to messenger RNA. This particular factor, known as Brother of the Regulator of Imprinted Sites (BORIS), promotes tumor growth.

Scientists were able to develop a vaccine from BORIS that was effective in helping stop the spread of a breast cancer-like tumor to other parts of the body, a process known as metastasis.

The vaccine "is capable of inducing strong and effective antitumor immunity, but the efficacy of this [strategy] could be even better if one could eliminate immune suppressor cells," lead researcher Michael G. Agadjanyan, head of the department of immunology and professor at the University of California, Irvine's Institute for Molecular Medicine, said in a press release.

Researchers tested the value of a mutated virus using the factor on mice with a form of cancer similar to breast cancer found in humans. They delivered the vaccine into the body by using immune cells known as dendritic cells, whose treelike branches form connections with other cells in the body.

The factor delivered by dendritic cells "elicited strong antitumor cellular immune responses in tumor-free mice," Agadjanyan said. "More importantly, therapeutic vaccination dramatically inhibited both tumor growth and the number of metastases in the lungs of tumor-bearing mice."

He cautioned, however, that the BORIS-based vaccine did not entirely eliminate tumors or stop the spread of cancer. For that reason, it should be combined with other strategies that enlist the immune system to combat cancer, he said.

The study findings were scheduled to be released Sunday at the annual meeting of the American Association for Cancer Research in Washington D.C.

More information

The U.S. National Cancer Institute has an A-to-Z list of cancer types.



-- Randy Dotinga



SOURCE: American Association for Cancer Research, press release, April 18, 2010.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Guillain-Barre Syndrome Very Rare After H1N1 Vaccine
2. Flu Vaccine With Both B Strains May Offer Better Protection
3. Vaccine Reverses Type 1 Diabetes in Mice
4. Clinical trial to test whether vaccine can effectively treat melanoma
5. Building a better flu vaccine: Add second strain of influenza B
6. Oral Vaccine May Help People With COPD
7. Genetic Engineering Raises Hope for Lyme Disease Vaccine
8. Only 1 in 4 Americans Got H1N1 Vaccine
9. Clues Found to How Different Flu Vaccines Work
10. GSK Joins Global Vaccine Alliance to Help Prevent Millions of Children from Contracting Pneumococcal Disease in the Worlds Poorest Countries
11. Miles for Hope’s Moving Towards A Cure(SM) Brain Tumor Walk in Boston Raising Funds for Brain Tumor Vaccine and Massachusetts General Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... firsts,: , TwinLink™ - the first dual ...
Breaking Medicine Technology: